Daiwa Securities Group
TARS icon

Daiwa Securities Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Daiwa Securities Group’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-137
Closed -$11K – 1419
2025
Q4 		$11K Hold
137
– – ﹤0.01% 1182
2025
Q3 		$8K Hold
137
– – ﹤0.01% 1174
2025
Q2 		$6K Hold
137
– – ﹤0.01% 1152
2025
Q1 		$7K Buy
137
+30
+28% +$1.48K ﹤0.01% 1116
2024
Q4 		$6K Hold
107
– – ﹤0.01% 1156
2024
Q3 		$4K Hold
107
– – ﹤0.01% 1188
2024
Q2 		$3K Hold
107
– – ﹤0.01% 1237
2024
Q1 		$4K Hold
107
– – ﹤0.01% 1228
2023
Q4 		$2K Hold
107
– – ﹤0.01% 1281
2023
Q3 		$2K Hold
107
– – ﹤0.01% 1227
2023
Q2 		$2K Hold
107
– – ﹤0.01% 1247
2023
Q1 		$1K Hold
107
– – ﹤0.01% 1283
2022
Q4 		$2K Buy
+107
New +$1.77K ﹤0.01% 1240

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return